Diplomat Pharmacy Inc (DPLO) Gross Profit Margin starting from the third quarter 2019 to third quarter 2018, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Diplomat Pharmacy Inc   (NYSE: DPLO)


Diplomat Pharmacy Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DPLO Gross Profit Margin (Sep 30 2019)
Q3 		(Jun 30 2019)
Q2 		(Mar 31 2019)
Q1 		(Dec 31 2018)
Q4 		(Sep 30 2018)
Q3
Y / Y Revenue Change -5.25 %
Seq. Revenue Change 1.05 %
Revenue In Millions $1,301.20
Gross Profit Margin 4.87 %
Gross Profit Margin Total Ranking # 3844
Gross Profit In Millions $63.39
Y / Y Gross Profit Change -32.11 %
Seq. Gross Profit Change -12.85 %


Commenting Third Quarter 2019 Gross Profit Margin
Company's Gross Profit Margin sequentially deteriorated to 4.87 % due to increase in Cost of Sales and despite Revenue increase of 1.05 % to $1,301 millions.
Diplomat Pharmacy Inc achieved highest Gross Profit Margin in III. Quarter


Observing third quarter 2019 results within Pharmacy Services & Retail Drugstore industry 14 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 3844, from total ranking in the previous quarter at 3873.
Learn about Gross Margin
DPLO's Gross Profit Margin third quarter 2019 Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 15
Retail Sector # 204
Overall # 3724

Gross Profit Margin Statistics
High Average Low
8.62 % 7.11 % 4.87 %
(Jun 30 2015)  


DPLO Gross Income Trends • More of DPLO's Profitabilty Ratios • DPLO Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
DPLO's Cumulative Gross Profit Margin
Pharmacy Services & Retail Drugstore Industry Gross Profit Margin Trends and Statistics
Retail Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
DPLO's Gross Profit Margin Profitability versus Pharmacy Services & Retail Drugstore Industry, Retail Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for DPLO's Competitors
Gross Profit Margin Profit Margin for Diplomat Pharmacy Inc 's Suppliers
Gross Profit Margin Profit Margin for DPLO's Customers

You may also want to know
DPLO's Annual Growth Rates DPLO's Profitability Ratios DPLO's Asset Turnover Ratio DPLO's Dividend Growth
DPLO's Roe DPLO's Valuation Ratios DPLO's Financial Strength Ratios DPLO's Gross Profit Growth
DPLO's Roa DPLO's Inventory Turnover Ratio DPLO's Growth Rates DPLO's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2019, within Pharmacy Services & Retail Drugstore Industry Gross Profit MarginSep 30 2019 MRQ Gross ProfitSep 30 2019 MRQ Revenue
Cosmos Health Inc   8.26 %$ 0.800  Millions$ 9.686  Millions
Mckesson Corporation  4.98 %$ 2,867.000  Millions$ 57,616.000  Millions
Diplomat Pharmacy Inc   4.87 %$ 63.385  Millions$ 1,301.197  Millions
Cardinal Health Inc   4.50 %$ 1,679.000  Millions$ 37,341.000  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.